Natco Pharma launches generic version of Tenofovir Alafenamide in India

Natco Pharma has launched a generic version of Tenofovir Alafenamide, which is used to treat chronic Hepatitis B in India. The company is one of the first entities to launch the generic version of the drug under its brand Tafnat. The company is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences. The drug is priced at Rs 1,900 for a monthly pack of 30 tablets for the Indian market

Company Profile : Natco Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*